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Abstract Purkinje cell dendritic development is severely
compromised after chronic activation of protein kinase C
(PKC). In a recent transgenic mouse model of spinocerebellar
ataxia 14, the ser361-to-gly (S361G) mutation of the protein
kinase C gamma (PKCγ) gene was expressed in Purkinje
cells. Purkinje cells from these mutant mice in organotypic
slice cultures have the same stunted dendritic tree as
Purkinje cells after pharmacological activation of PKC.
Because the transgene is exclusively present in Purkinje cells,
cerebellar tissue from these mice is an attractive starting ma-
terial for searching genes which might be interacting with
PKCγ in Purkinje cells for inducing the stunted dendritic
growth. We have performed a microarray analysis and identi-
fied several candidate genes with an increased messenger
RNA (mRNA) expression in the PKCγ-S361G transgenic
Purkinje cells. Out of these candidates, we have further stud-
ied carbonic anhydrase 8 (CA8). We show here that CA8
mRNA and protein expression is strongly induced in PKCγ-
S361G transgenic Purkinje cells. Overexpression of CA8 in
Purkinje cells in dissociated cultures strongly inhibited
Purkinje cell dendritic development and produced a dendritic
phenotype similar to PKCγ-S361G. There was no evidence
for a direct binding of CA8 to either PKCγ or the type 1 IP3
receptor. Knockdown of CA8 with miRNA did not alter
Purkinje cell dendritic development and did not protect
Purkinje cells in dissociated cultures from the stunted dendrit-
ic growth induced by PKCγ-S361G or by PKC activation.
Our results indicate that CA8 is a novel important regulator
of Purkinje cell dendritic development and that its expression
is controlled by PKCγ activity.
Keywords Purkinje cell dendritic development . Protein
kinase C gamma . Spinocerebellar ataxia type 14 . Carbonic
anhydrase 8
Introduction
The signaling molecule protein kinase C (PKC) plays an im-
portant role for long-term depression of Purkinje cells [1] and
has a strong negative impact on Purkinje cell dendritic growth
and development [2–4]. Increased PKC activity is likely to
affect the long-term calcium equilibrium of the Purkinje cells.
Blockade of voltage-gated calcium channels could partially
protect Purkinje dendrite cells from the stunted growth seen
with increased PKC activity [5], and Purkinje cells from
Moonwalker (Mwk) mutant mice with increased calcium in-
flux through TRPC3 channels also show a stunted dendritic
morphology [6]. Similarly, inhibition of the plasmamembrane
calcium-ATPase 2 (PMCA2) affected Purkinje cell dendritic
growth [7, 8]. These findings demonstrate the involvement of
the calcium equilibrium for regulating Purkinje cell dendritic
growth, but still very little is known about the downstream
molecular interactions after PKC activation in Purkinje cells
leading to the reduced dendritic growth. Interestingly, one
form of spinocerebellar ataxias, SCA 14, is caused by point
mutations in the protein kinase C gamma (PKCγ) gene [9, 10]
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and there is evidence that at least some of the missense muta-
tions may confer a gain of function phenotype with a consti-
tutive activation of PKCγ [11, 12]. We have recently created a
transgenic mouse model of SCA 14 by introducing a trans-
gene carrying the ser361-to-gly (S361G) mutation of the PKC
gene specifically into Purkinje cells. This mutation is located
in the catalytic domain [13] and was shown previously to
confer an increased catalytic activity as tested by in vitro as-
says [12]. PKCγ-S361G transgenic mice have pathological
changes typical for cerebellar disease and have an increased
PKCγ activity in vivo reflected by the reduced dendritic de-
velopment typically seen with increased PKC activity [14].
Purkinje cells from these mutant mice thus show both an in-
creased PKCγ activity and a severe dendritic reduction.
Because the transgene is exclusively activated in Purkinje
cells, cerebellar tissue from these mice is an attractive starting
material for searching other genes which might be interacting
with PKCγ for inducing the stunted dendritic growth. We
have performed a gene chip microarray analysis and identified
several candidate genes with an increased messenger RNA
(mRNA) expression in the PKCγ-S361G transgenic
Purkinje cells. Out of these candidate genes, we have further
studied carbonic anhydrase 8 (CA8) which was shown previ-
ously to be involved in Purkinje cell function and cerebellar
disease [15, 16]. We show here that CA8 mRNA and protein
expression is strongly induced after PKC activation and that
overexpression of CA8 in cultures of dissociated Purkinje
cells strongly inhibits Purkinje cell dendritic development.
However, we found no evidence of a binding of CA8 to either
PKCγ or the type 1 inositol 1,4,5-triphosphate (IP3) receptor.
Knockdown of CA8 protein expression by microRNA
(miRNA) transfection did not protect Purkinje cells in disso-
ciated cultures from the stunted dendritic growth after in-
creased PKCγ activity. Our results indicate that CA8 is an
important regulator of Purkinje cell dendritic development
and that its expression is controlled by PKCγ activity.
Materials and Methods
Plasmid Construction
Plasmid L7-green fluorescent protein (GFP) was previously
described [17]. CMV-CA8 and CMV-PKCγ plasmids were
from Origene (Rockville, MD, USA). Restriction sites were
added to the CA8 and PKCγ genes by polymerase chain re-
action (PCR) using the following primers: forward primer for
CA8, 5′CAG GAT CCA GCG GCC GCA TGG CTG ACC
TGA GCT TC3′; reverse primer for CA8, 5′CCC TTG CTC
ACC ATG GCC TGA AAG GCC GCT CGG A3′; forward
primer for PKCγ, 5′CAG GAT CCA GCG GCC GCATGG
CTGGTC TGGGCC CC 3′; and reverse primer for PKCγ, 5′
CCCTTGCTCACCATGGCCATGACGGGCACAGGC
A3′. These PCR products were incubated with the L7-GFP
vector in the presence of the restriction enzymes, NotI and
NcoI (New England BioLabs, Massachusetts, USA) in suit-
able buffer. After 30-min incubation at 37 °C, DNA fragment
and linearized vector were fused using In-Fusion HD Cloning
Kits (Clontech, Mountain View, CA). The constructed expres-
sion vectors were confirmed by DNA sequencing
(Microsynth, Balgach, Switzerland).
Organotypic Slice Cultures
Animal experiments were carried out in accordance with the
EU Directive 2010/63/EU for animal experiments and were
reviewed and permitted by Swiss authorities. Cultures were
prepared from B6CF1 (CB6) mice or PKCγ-S361G transgen-
ic mice [14] as described previously [18]. Briefly, mice were
decapitated at postnatal day 8 (P8), their brains were asepti-
cally removed, and the cerebellum was dissected in ice-cold
preparation medium (minimal essential medium (MEM) with
1 % glutamax (Life Technologies, Zug, Switzerland), pH 7.3).
Sagittal sections, 350 μm thick, were cut on a McIlwain tissue
chopper under aseptic conditions. Slices were separated, trans-
ferred onto permeable membranes (Millicell-CM, Merck-
Millipore, Zug, Switzerland), and incubated on a layer of
Neurobasal medium (97 % Neurobasal medium, 2 % B27
supplement, 1 % glutamax, pH 7.3) in a humidified atmo-
sphere with 5 % CO2 at 37 °C. The medium was changed
every 2–3 days for a total of 5 days for microarray analysis
and of 7 days for protein analysis and immunostaining.
Microarray Analysis
Starting material for the microarray analysis were cerebellar
slice cultures from PKCγ-S361G transgenic mice versus con-
trol mice. After 5 days in vitro (DIV 5), organotypic cerebellar
slices were washed, harvested, and submerged in RNA later
(Life Technologies, Zug, Switzerland) solution for storage.
The slices from one litter deriving from three to four mouse
pups were collected and used for RNA purification. Purified
total RNAwas amplified by in vitro transcription and convert-
ed to sense-strand complementary DNA (cDNA).
Fragmented cDNA samples were then hybridized to
GeneChip Mouse Gene 1.0 ST Arrays (Affymetrix, Santa
Clara, CA, USA). Procedures were carried out as described
by the manufacturers, and the analysis was done in the Life
Science Training Facility (LSTF) core facility of the
University of Basel by Dr. Philippe Demougin. Raw data
were processed and analyzed using Partek Genomics Suite
(version 6.12.0907). Transcripts were considered to be
changed if the p value was smaller than 0.05. After filter-
ing, 1045 genes were retained. We then set the threshold at
a fold change exceeding 1.25 for being specifically
expressed, and 98 genes were retained.
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Reverse Transcriptase-Quantitative PCR
Total RNA was extracted from organotypic cerebellar slices
harvested at DIV 5–7, and cDNA was synthesized with re-
verse transcriptase-quantitative PCR (RT-qPCR) using
oligo(dT) primers (Applied Biosystems, Foster City, CA).
For gene expression analysis, RT-qPCRs were conducted in
a total volume of 20 μl comprising 10 μl of Mastermix with
SYBR Green (Applied Biosystems, Foster City, CA), 0.5 μl
of each primer (1.0 μM), 0.3 μl of sample cDNA, and 8.5 μl
ultrapure water. Real-time PCRs were run on a Real-Time
PCR System (Applied Biosystems, Foster City, CA) under
the following reaction conditions: 1 cycle of [95 °C for
10 min], 40 cycles of [94 °C for 15 s→65 °C for 60 s], and
1 cycle of [95 °C for 15 s→72 °C for 30 s→95 °C for 15 s].
Oligonucleotide primers were designed using the Primer3
software (http://bioinfo.ut.ee/primer3/). The primer
sequences are given in supplementary methods. Reactions
were quantified by relative standard curve system and the
cycle threshold (Ct) method using the SDS2.2 software
(Applied Biosystems, Foster City, CA). A relative quantitation
value (RQ) for each sample from the triplicates of that sample
was calculated for each gene. The data were analyzed as RQ
for the gene of PKCγ transgenic mice/RQ for control mice.
For each comparison, a minimum of three independent exper-
iments were done with unrelated RNA samples.
Western Blot Analysis
Tissue slices were harvested with a cell scraper. Samples were
then homogenized in radioimmunoprecipitation assay (RIPA)
buffer with phosphatase inhibitor (phosphor STOP, Roche,
Basel, Switzerland) and protease inhibitor (cOmplete
Protease Inhibitor Cocktail Tablets, Roche, Basel,
Switzerland). Homogenates were sonicated for 5 s a total of
five times and cleared by centrifugation at 14,000×g for
15 min at 4 °C. Protein concentrations were determined with
NanoDrop (Thermo Scientific, Reinach, Switzerland).
Western blotting analysis was performed by standard proto-
cols. Membranes were blocked with 5 % BSA in tris-buffered
saline (TBS) for 1 h and incubated with appropriate primary
antibodies. Rabbit anti-inositol 1,4,5-trisphosphate receptor 1
(ITPR1) (Cell Signaling,Massachusetts, USA, 1:1000), rabbit
anti-CA8 (Novus Biologicals, Colorado, USA, 1:2000), rabbit
anti-PKCγ (Santa Cruz Biotechnology, Santa Cruz, CA,
1:1000), rabbit anti-family with sequence similarity 40, mem-
ber B (Fam40b) (AVIVA, San Diego, USA, 1:1000), rabbit
anti-pleckstrin homology domain containing, family D
(Plekhd1) (Thermo Scientific, Reinach, Switzerland,
1:1000), rabbit anti-Homer3 (Abgent Inc., San Diego, CA,
USA, 1:1000), mouse anti-metabotropic glutamate receptor
1 (mGluR1) (BD Biosciences, Franklin Lakes, NJ, USA,
1:1000), or anti-β-actin (Millipore, Zug, Switzerland,
1:1000) were used. After washing with TBS-T, membranes
were incubated with HRP-labeled secondary antibodies for
1 h. After washing, bound antibodies were visualized with
ECL2 Western blotting substrate (Pierce, Thermo Scientific,
Reinach, Switzerland) and quantified using a C-DiGitWestern
blot scanner and software (LI-COR Biosciences, Bad
Homburg, Germany). For each comparison, a minimum of
three independent experiments were done with unrelated pro-
tein samples.
Immunoprecipitation
Cerebellar slice cultures at DIV 7 were used as starting mate-
rial. Slice cultures were harvested with a cell scraper. Samples
were then homogenized in RIPA buffer with phosphatase in-
hibitor and protease inhibitor as described in Western blot
analysis. Homogenates were sonicated for 5 s a total of five
times and cleared by centrifugation at 14,000×g for 15 min at
4 °C, and protein concentrations were determined and 100 μg
of each sample was used for immunoprecipitation. Before
using, Protein G was washed twice at 12,000g for 10 s with
PBS. Lysate was incubated with 50 μl Protein G for 30 min at
4 °C, and lysate was washed twice at 12,000g for 10 s with
PBS. One microgram antibody, 50 μl pre-washed Protein G,
and 50 μl PBS were added to the lysate and rotated at 4 °C
overnight. Tubes were then centrifuged at 4 °C for 2 min at
3000g and washedwith 1ml PBS 4 °C for 2 min at 3000g four
times. SDS-PAGE and Western blot were done as described.
A minimum of three independent immunoprecipitation exper-
iments with unrelated protein samples were done per
condition.
Immunohistochemistry
At DIV 7, slices were fixed in 4 % paraformaldehyde over-
night at 4 °C. All reagents were diluted in 100 mM phosphate
buffer (PB), pH 7.3. Slices were incubated in blocking solu-
tion (0.5 % Triton X-100, 3 % normal goat serum) for 1 h at
room temperature. Two different primary antibodies were si-
multaneously added to the slices in fresh blocking solution
and incubated overnight at 4 °C. After washing in PB, sec-
ondary antibodies were added to the slices in PB containing
0.1 % Triton X-100 for 2 h at room temperature. For the
analysis of protein expression in Purkinje cells, mouse anti-
Calbindin D-28K (Swant, Marly, Switzerland, 1:1000), poly-
clonal rabbit anti-GFP (Abcam, Cambridge, UK, 1:1000),
rabbit anti-CA8 (Novus Biologicals, Colorado, USA,
1:2000), mouse anti-ITPR1 (Abcam, Cambridge, UK,
1:100), rabbit anti-ITPR1 (Millipore, Zug, Switzerland,
1:2000), or rabbit anti-PKCγ (Santa Cruz Biotechnology,
Santa Cruz, CA, 1:1000) were used as primary antibodies,
and goat anti-mouse Alexa 568 (Molecular Probes, Eugene,
OR, 1:1000) and goat anti-rabbit Alexa 488 (Molecular
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Probes, Eugene, OR, 1:1000) were used as secondary antibod-
ies to visualize Purkinje cells. Stained slices were mounted on
cover slips with Mowiol (Sigma-Aldrich, Buchs,
Switzerland). Cultures were viewed on an Olympus AX-70
microscope equipped with a Spot digital camera. Recorded
images were adjusted for brightness and contrast with
Photoshop image processing software.
Histology
Mice were deeply anesthetized, perfused through the aorta
with 4 % paraformaldehyde, and cryoprotected with 30 %
sucrose overnight. Brains were embedded in tissue freezing
medium (OCT), frozen, and sectioned using a Leica cryostat
CM1900. Sagittal sections (25 μm) were examined by immu-
nohistochemical staining.
Plasmid Transfection of Purkinje Cells in Dissociated
Cerebellar Cultures
Dissociated cerebellar cultures were prepared from mice es-
sentially as described [17] except that the cells were obtained
from postnatal day 0 (P0) mice. The transfection of the cells
was performed using a Nepa21 electroporator (NEPAGENE,
Japan) according to manufacturer’s instructions. One hundred
microliters of the Opti-MEM (Life Technologies, Zug,
Switzerland) solution was mixed with the plasmid DNA to
be transfected. This mixture was then used to suspend the
cerebellar cell pellet. The cell suspension was transferred into
one of the cuvettes provided in the kit and subjected to the
optimized electroporation program.
After transfection, cells were plated in glass chambers that
had been coated with poly-L-lysine containing 90 % v/v
Dulbecco’s modified Eagle medium/F-12 nutrient-based me-
dium (DFM), 1 % N-2 supplement, 1 % glutamax, and
10 % v /v FBS (all from Life Technologies, Zug,
Switzerland); pH was adjusted to 7.2–7.4. Two hours after
transfection, 0.8-ml DFM, containing 1 % N-2 supplement
and 1 % glutamax at 37 °C, was added to each dish. After that,
half of medium was changed once or twice a week. After 14–
18 days, cells were fixed in 4 % paraformaldehyde for 1 h at
4 °C and processed for immunohistochemistry as described. A
minimum of three independent transfection experiments using
different dissociated cultures were done for each plasmid.
Knockdown of CA8 Expression
miRNAs were designed and generated by Life Technologies,
Zug, Switzerland to target CA8 (for details see supplementary
methods). Each miRNA was cloned into the BLOCK-iT™
Pol II miR RNAi expression vector according to the instruc-
tions of the manufacturer and then sequenced (Microsynth,
Balgach, Switzerland). In order to test the knockdown
efficacy, the different miRNA vectors together with a CA8
expression vector were transfected into HeLa cells using
Lipofectamin 2000 (Life Technologies, Zug, Switzerland).
The most efficient pcDNA6.2-GW/miRNA expression vec-
tors containing CA8-specific miRNAs were subcloned to
pL7 in order to transfect miRNA to Purkinje cells. In order
to monitor miRNA transfection, a GFP reporter was included
in the miRNA vectors. Dissociated cerebellar cultures cells
were electroporated using Nepa21 (NEPAGENE, Japan) ac-
cording to manufacturer’s instructions and cultured as de-
scribed. A minimum of three independent transfection exper-
iments using different dissociated cultures were done for each
plasmid.
Statistical Analysis of Purkinje Cell Dendritic Tree Size
The quantification of Purkinje cell dendritic tree size and
counting of branch points from organotypic slice cultures or
dissociated Purkinje cell cultures were done as previously de-
scribed [5]. Purkinje cells which had a dendritic tree isolated
from its surroundings were selected for analysis. An image
analysis program (Image Pro Plus or ImageJ) was used to trace
the outline of the Purkinje cell dendritic trees yielding the area
covered by the dendritic tree. Over 20 cells per experimental
condition originating from at least three independent experi-
ments were acquired and analyzed using GraphPad Prism
software (San Diego, USA). The statistical significance of
differences in parameters was assessed by a non-parametric
Mann-Whitney’s test. Confidence intervals were 95 %; statis-
tical significance was assumed when p<0.05.
Results
Upregulated Genes in PKCγ-S361G Transgenic Mice
Identified by Gene Chip Analysis
We have previously reported that PKCγ-S361Gmice carrying
a human SCA 14 allele with Purkinje cell-specific expression
showed an increased PKCγ activity in Purkinje cells leading
to abnormal morphology of Purkinje cells, a phenotype which
is very similar to the one found after pharmacological treat-
ment of PKC stimulator [14]. In contrast to pharmacological
stimulation, the increased PKC activity in PKCγ transgenic
mice is Purkinje cell specific, offering the possibility to search
for downstream targets of PKCγ-S361G signaling which
might be involved in the inhibition of Purkinje cell dendritic
growth.
In order to search for transcripts with altered expression in
Purkinje cells of PKCγ-S361G transgenic mice, we used the
Affymetrix GeneChip Mouse Gene 1.0 ST Array comparing
samples of cerebellar slice cultures from PKCγ transgenic
mice to control mice. The microarray analysis was performed
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twice using two independent samples from different culture
experiments. We could identify 98 genes which were upregu-
lated and 17 genes which were downregulated in PKCγ-
S361G transgenic mice based on a change of more than
1.25-fold (the complete microarray data sets are available
from the authors on request). The rather moderate changes
in expression of most transcripts could be explained by the
fact that the Purkinje cell population is very small and only
comprises around 0.1 % of the total cells of the cerebellum of
adult rodents [19]. We focused on upregulated genes because
our previous studies had shown that PKCγ-S361G transgenic
mice had an increased activity of PKC, and we searched for
candidates which might be involved in PKC signaling.
Out of the 98 upregulated genes, we selected eight genes
for further analysis based on their expression level in Purkinje
cells in situ and their presumed function (Table 1). A brief
description of the main features of the eight candidate genes
is given in the Supplementary Table 1. The expression of the
mRNA of the eight candidate genes was verified using the
Allen Brain Atlas. The in situ hybridization data from the
Allen Brain Atlas (http://mouse.brain-map.org/) confirm that
all of the eight selected candidate genes are strongly expressed
in Purkinje cells. For several of these genes, an important role
for Purkinje cell differentiation and function has already been
suggested (Supplementary Table 1).
RT-qPCR Analysis and Western Blotting Confirm
the Upregulation of Candidate Genes
In order to confirm the GeneChip microarray results (Fig. 1a),
we performed RT-qPCR assays using cerebellar slice cultures.
As expected, all of the candidate genes were upregulated in
the cerebellar slice cultures from PKCγ-S361G transgenic
mice (Fig. 1b). In order to confirm the increased expression
of candidates on the protein level, we performed Western blot
analysis. After 7 days of culture (DIV 7), cerebellar slice cul-
tures of control mice and PKCγ-S361G transgenic mice were
collected and candidate proteins were detected with Western
blotting. At DIV 7, there is a strong reduction of the dendritic
expansion of Purkinje cells in slice cultures from PKCγ-
S361G transgenic mice [14]. In PKCγ-S361G transgenic
mice, the PKCγ protein expression level is higher than that
of control (Fig. 2a). Notably, fold change of PRKCG gene in
GeneChip microarray was around 1.6 (data not shown).
Within the candidates, the protein expression of CA8,
Fam40b, and Plekhd1 was induced in PKCγ-S361G transgen-
ic mice (Fig. 2b, c). CA8 was more than five times upregulat-
ed, while Fam40b and Plekhd1 were only slightly up at
around 1.3 of control levels. As for the other candidates, either
we could not see a strong difference in protein expression or
no antibody suitable for Western blot analysis is available so
far. Therefore, further analysis was restricted to CA8,
Fam40b, and Plekhd1.
CA8 Is Specifically and Strongly Expressed in Purkinje
Cells
To determine the expression pattern of CA8 in brain, we
performed immunohistochemical analysis on mid-sagittal
brain sections of postnatal day 14 (P14) wild-type mice
and PKCγ-S361G transgenic mice. Purkinje cells were
identified by staining for Calbindin-D28K together with
CA8. We found that CA8 was specifically expressed in
Purkinje cells and that the staining intensity was higher in
PKCγ-S361G transgenic mice (Fig. 3a, b). Further, we
performed immunostaining in organotypic slice cultures.
CA8 was again most strongly expressed in cultures de-
rived from PKCγ-S361G transgenic mice (Fig. 3c, d).
These results suggest that CA8 is specifically expressed
in Purkinje cells and that the expression level is induced
by the PKCγ-S361G transgene.
Immunostaining for Fam40b and Plekhd1 with commercial-
ly available antibodies did not give satisfactory results and
showed either no staining or only poor staining intensity on
sections or organotypic cerebellar slice cultures. Therefore, we
did not further analyze these candidates and focused on CA8.
The Inositol 1,4,5-Trisphosphate Receptor 1 (ITPR1)
Is Also Induced in PKCγ-S361G Transgenic Mice
CA8, CA10, and CA11 are called carbonic anhydrase-related
proteins (CARPs) because they lack classical carbonic
anhydrase enzymatic activity due to the missing catalytic
zinc-coordinating residues [20]. Thus, their biological func-
tions are still unclear. Hirota et al. [21] showed that CARPs
bind to ITPR1 using a yeast hybrid system and also found
abundant co-expression and co-localization of CARP and
ITPR1 in Purkinje cells. The ITPR1 functions as a ligand-
gated ion channel that releases Ca2+ from intracellular stores
[22]. We analyzed the ITPR1 expression level in PKCγ-
Table 1 Gene chip microarray results of candidate genes
Gene p Value Fold change
Bcl11a 0.036643 1.412
CA8 0.023265 1.63062
Chn1 0.011644 1.47505
Fam40b 0.045992 1.92428
Klhl4 0.025187 1.9327
Lhx1 0.007259 1.36811
Plekhd1 0.000103 1.38
Ywhah (14-3-3eta) 0.024979 1.29995
For the eight selected candidate genes, the induction ofmRNA expression
in PKCγ-S361G transgenic mice compared to control mice (fold change)
and the p values of for the significance of the change are shown
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S361G transgenic mice. Although we had not identified
ITPR1 as a candidate in our GeneChip microarray because
the p value was above 0.05 (p value was 0.052 and fold
change was 1.42), ITPR1 mRNA was induced in PKCγ-
S361G transgenic mice when tested with RT-qPCR
(Fig. 4a). Western blotting analysis confirmed that ITPR1 pro-
tein is strongly upregulated in PKCγ-S361G transgenic mice
(Fig. 4b, c). Immunofluorescence-staining results showed spe-
cific expression in Purkinje cells which was increased in
PKCγ-S361G transgenic mice (Fig. 4d, e).
No Evidence for a Binding Between CA8 and ITPR1
in Cerebellar Purkinje Cells
The co-expression of ITPR1 and CA8 in Purkinje cells
and the induction of both proteins by increased PKCγ
activity raise the question about a direct interaction of
ITPR1 and CA8 in Purkinje cells. Binding of CA8 to
ITPR1 has been previously shown using a glutathione
S-transferase (GST) pull-down assay with recombinant
proteins, but it is not known whether such an interaction
also occurs endogenously in Purkinje cells. In order to
identify an interaction in Purkinje cells, we have carried
Fig. 1 Gene chip and
quantitative RT-PCR data for
cerebellum of PKCγ-S361G
transgenic mice and control mice
(a). Induction of the expression of
the eight selected candidate genes
as found in the gene chip assay
(b). Quantitative RT-PCR
confirmed that all candidates are
upregulated in PKCγ-S361G
transgenic mice
Fig. 2 Western blot analysis of cerebellum of PKCγ-S361G transgenic
mice and control mice (a). Protein expression of PKCγ is increased in the
cerebellum of PKCγ-S361G transgenic mice. β-Actin was used as a
loading control. b Western blot results of CA8, Fam40b, and Plekhd1.
β-Actin as loading control. c Quantitation of Western blot data. Signal
intensity of each candidate was normalized with β-actin. Data were from
three independent experiments, and signal intensity of samples from con-
trol mice was set to one
Fig. 3 Immunofluorescence-staining analysis of cerebellum of PKCγ-
S361G transgenic mice and control mice. a–f Immunofluorescence stain-
ing of frozen section from P14 control mice in a–c and from PKCγ-
S361G mice in d–f with anti-Calbindin-D28K (a, d) and with anti-CA8
(b, e). Merged images in (c, f). g–l Immunofluorescence staining of cer-
ebellar slice cultures after 1 week in vitro. Cultures from control mice in
g–i and from PKCγ-S361Gmice in j–l stainedwith anti-Calbindin-D28K
(g, j) and with anti-CA8 (h, k). Merged images in (i, l). Note the strong
induction of anti-CA8 immunostaining in PKCγ-S361G cerebellum.
Scale bar in H=50 μm
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out co-immunoprecipitation using lysates from cerebellar
slice cultures. Using this assay, we were unable to detect
an interaction between ITPR1 and CA8 (Fig. 5) in cere-
bellar tissue. Furthermore, no interaction of CA8 and
ITPR1 was detected using the Duolink proximity ligation
assay (data not shown). Our data do not support the idea
of a direct binding of CA8 and ITPR1 in cerebellar
Purkinje cells.
CA8 Overexpression in Purkinje Cells Inhibits Purkinje
Cell Dendritic Development
In order to characterize the functions of CA8 on dendritic
development of Purkinje cells, we performed transfection
experiments in dissociated cerebellar cell cultures with a
Purkinje cell-specific expression vector based on the L7
promoter [17]. The L7 promoter plasmid was transfected
by electroporation and efficiently and selectively mediat-
ed expression of the transfected genes in Purkinje cells at
a high rate and with a continued expression for more than
3 weeks. We first transfected a plasmid containing the
mutated PKCγ-S361G construct that was used for the
generation of the PKCγ-S361G transgenic mice [14].
Control Purkinje cells in these cultures transfected with
a GFP plasmid showed a well-developed branched den-
dritic tree (Fig. 6c) which was indistinguishable from that
of non-transfected Purkinje cells (Fig. 6a). In contrast,
Purkinje cells transfected with the PKCγ-S361G plasmid
developed only very small dendritic trees with little
branching (Fig. 6d). This morphology was indistinguish-
able from that of Purkinje cells derived from PKCγ trans-
genic mice (Fig. 6b). This finding confirms that the
dissociated cultures are useful for studying some aspects
of Purkinje cell dendritic development and that the PKCγ-
mediated inhibition of Purkinje cell dendritic growth is
present in the dissociated cultures. We then transfected a
plasmid containing the CA8 gene inducing an overexpres-
sion of CA8 in the transfected Purkinje cells. CA8 over-
expression resulted in a strong inhibition of Purkinje cell
dendritic development compared to control Purkinje cells
(Fig. 6e) with a morphology of the dendritic tree in
transfected cells (Fig. 6f) very similar to that after trans-
fection of the PKCγ-S361G containing plasmid (Fig. 6d).
Quantitative measurements of the size of the Purkinje cell
Fig. 4 ITPR1 is induced in
PKCγ-S361G transgenic mice
(a). Quantitative RT-PCR
showing upregulation of ITPR1
but not ITPR2 and ITPR3 in
PKCγ-S361G. bWestern blot
results of ITPR1 from cerebellum
of control and PKCγ-S361G
transgenic mice. β-Actin as
loading control. c Quantitation of
Western blot data. Signal intensity
was normalized with β-actin. d, e
Anti-ITPR1 immunostaining of
cerebellar slice cultures after
1 week in vitro. Note the strong
induction of anti-ITPR1
immunostaining in PKCγ-S361G
slices (e) versus control slices (d).
Scale bar in E=50 μm
Fig. 5 Co-immunoprecipitation for CA8, ITPR1, PKCγ, and Homer3.
At DIV 7, cerebellar slices were lysed (see BMaterials andMethods^) and
subjected to co-immunoprecipitation analysis. Western blots with the
antibodies indicated at the left margin of co-immonoprecipitates from
the antibodies indicated in the top line. Immunoprecipitation was only
observed for the protein of the antibody used, and no co-
immunoprecipitation of other proteins was found
accepted manuscript
dendritic tree with the different transfections confirm that
both PKCγ-S361G and overexpression of CA8 lead to a
severe and similar reduction of the size of Purkinje cell
dendritic trees (Fig. 6g–i). Our findings show that CA8
overexpression has similar effects on Purkinje cell den-
dritic development as a strong activation of PKCγ and
suggest that PKCγ and CA8 may be acting in the same
or related signaling pathways within Purkinje cells.
miRNA-Mediated Suppression of CA8 Protein
Does Not Protect From Reduction of Dendritic Growth
by Increased Activity of PKC
Our finding that overexpression of CA8 reduces dendritic
growth raises the question whether CA8 might be part of a
signaling complex which converts increased PKC activity
into reduced dendritic growth. We have therefore aimed at
suppressing the expression of CA8 protein in Purkinje cells
by miRNA transfection. In order to knock down CA8 pro-
tein expression in Purkinje cells, we used two different
miRNAs, mi327 and mi616, which were selected based
on their knockdown efficiency in HeLa cells and which
were cloned into the L7 promoter plasmid together with a
GFP reporter (for details, see supplementary methods).
mi327- and mi616-transfected Purkinje cells showed a
greatly reduced CA8 expression as revealed by immuno-
histochemistry (Fig. 7d, f, h) compared to control miRNA-
transfected (Fig. 7a) or miRNA-non-transfected cells.
Purkinje cells with a CA8 knockdown displayed a rather
normal morphology with no significant reduction of the
size of the dendritic tree (Fig. 7c). When CA8 knockdown
was combined with stimulation of PKC activity with
phorbol-12-myristate-13-acetate (PMA), the CA8 knock-
down did not provide any protection from the reduction
of the dendritic tree seen under these conditions (Fig. 7e,
f). A similar result was obtained when CA8 knockdown
was done in Purkinje cells from PKCγ-S361G transgenic
mice. The CA8 knockdown did not rescue the dendritic
tree from the severe reduction typical for this condition
(Fig. 7g, h). A quantitative evaluation of the dendritic tree
sizes is shown in Fig. 7i confirming the qualitative find-
ings. These data indicate that the signaling from PKCγ to
the control of dendritic growth in Purkinje cells does not
require a strong contribution of CA8 protein function.
Discussion
Using a transgenic mouse model expressing a constitutive
active form of PKC specifically in Purkinje cells, we have
identified several candidate genes which might be involved
in the stunted dendritic growth of Purkinje cells seen after
PKC activation. One of these candidate genes, CA8, has a
greatly increased mRNA and protein expression after PKC
activation. Overexpression of CA8 in cultures of dissociated
Purkinje cells strongly inhibited Purkinje cell dendritic devel-
opment. Knockdown of CA8 protein expression by miRNA
transfection did not protect Purkinje cells in dissociated cul-
tures from the stunted dendritic growth after increased PKCγ
activity. Our results show that CA8 is an important regulator
of Purkinje cell dendritic development and that its expression
is controlled by PKCγ activity.
Fig. 6 Morphology of Purkinje cells after PKCγ-S361G and CA8
transfection after 2 weeks in vitro. Immunostaining with anti-
Calbindin-D28K (a, b) or anti-GFP (c–f). a Purkinje cells from
control mice in dissociated culture with expanded dendritic trees.
b Purkinje cell from PKCγ-S361G transgenic mice with very small
dendritic trees. c Purkinje cells transfected with a control GFP vec-
tor with normal dendritic expansion. d Purkinje cells transfected
with a PKCγ-S361G-GFP vector with small dendritic trees similar
to those of PKCγ-S361G transgenic mice. e Purkinje cells
transfected with a control GFP with normal dendritic expansion. f
Purkinje cells transfected with a CA8-GFP vector also with small
dendritic trees. Scale bar in H=50 μm. g–i Quantification of the
total dendritic area of Purkinje cells in the transfection experiments.
The analysis shows that Purkinje cells transfected with PKCγ-
S361G (h) or CA8 (i) had very small dendritic trees similar to those
of Purkinje cells from PKCγ-S361G transgenic mice (g). The num-
ber of measured cells (n) was 20 for all experiments, and the results
were statistically significant with p<0.0001 in all conditions. Error
bars represent the SEM
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Genes with Increased mRNAExpression in Purkinje Cells
with Activated PKCγ
Increased activity of PKC in Purkinje cells results in a dramat-
ic reduction of dendritic outgrowth and in the formation of a
greatly reduced dendritic tree. The downstream signaling
events converting the activation of PKC to reduced dendritic
growth are still very unclear.We have used a transgenicmouse
model expressing a mutant PKCγ with increased catalytic
activity specifically in Purkinje cells resulting in stunted den-
dritic growth [14] as starting point for searching for genes with
an increased expression in such Purkinje cells using a gene
chip approach. We have identified many candidate molecules,
although the observed upregulation was typically only in the
range of 1.5–1.2× the original expression. The rather moderate
changes in expression of most transcripts could be explained
by the fact that the Purkinje cell population is very small and
only comprises around 0.1 % of the total cells of the cerebel-
lum of adult rodents [19]. When we confirmed the increased
expression of some of the candidates by RT-qPCR, we actu-
ally found factors of 2 and more (Fig. 1). All of the selected
candidate molecules are expressed in Purkinje cells and have
the potential to be involved in PKC signaling and Purkinje cell
dendritic development (see Supplementary Table 1). We de-
cided to focus the further analysis on CA8 because it was the
only candidate molecule for which commercially available
antibodies gave satisfactory results in Western blotting and
immunohistochemistry, both of which were required for fur-
ther analysis of a potential function in Purkinje cell dendritic
development.
CA8 is a carbonic anhydrase lacking enzymatic activity
[20]. In the wdl mouse mutant with a 19-base-pair deletion
Fig. 7 Morphology of Purkinje cells after CA8miRNA-mediated knock-
down after 2 weeks in vitro. Immunostainingwith anti-GFP (a, c, e, g, i, l)
or anti-CA8 (b, d, f, h, k, m). a, b Control miRNA-GFP-transfected
Purkinje cells express the GFP reporter (a) and show normal CA8 immu-
nostaining (b) and a normal morphology. c, d A Purkinje cell transfected
with CA8 miRNA-GFP expresses GFP and shows a normal morphology
(c). A non-transfected Purkinje cell is well stained in the anti-CA8 im-
munostaining, whereas the CA8 miRNA-GFP-transfected Purkinje cell
(arrow) is almost not visible. e, f Treatment with the PKC stimulator
PMA dramatically reduced dendritic growth. e Anti-GFP immunostain-
ing and f anti-CA8 immunostaining. Transfection with CA8 miRNA-
GFP strongly reduced the CA8 immunostaining but did not protect from
the PMA-induced dendritic reduction. g, h Purkinje cell from a PKCγ-
S361G transgenic mouse with strongly reduced dendrites. g Anti-GFP
immunostaining and h anti-CA8 immunostaining. Transfection with CA8
miRNA-GFP strongly reduced the CA8 immunostaining but did not pro-
tect from the dendritic reduction. Scale bar inH=50 μm. iQuantification
of the dendritic area of Purkinje cells in the CA8 miRNA-GFP transfec-
tion experiments. The analysis shows that transfectionwith CA8miRNA-
GFP could not rescue the dendritic tree size after stimulation with PMA
(labeled WT+PMA) or in PKCγ-S361G transgenic Purkinje cells
(labeled Tg). The data include control experiments with transfections of
a control miRNA-GFP plasmid for which no images are shown in (a–h).
The number of measured cells (n) was 20 for all experiments, and the
reduction of the dendritic tree in the experiments with either PMA treat-
ment or PKCγ-S361G transgenic mice was statistically significant with
p<0.0001 in all conditions irrespective of the presence of miRNA. Error
bars represent the SEM
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in the CA8 gene, the loss of function of CA8 results in ataxia
[15] and synaptic changes in the cerebellum [16] which are
associated with alterations in calcium signaling [23]. CA8
knockdown in zebrafish resulted in abnormal cerebellar de-
velopment and ataxia [24]. Mutations in the human CA8 gene
were identified which are associated with cerebellar ataxia and
mild cognitive retardation [25, 26], and antibodies directed
against CA8 have been identified as a cause of Purkinje cell
degeneration and cerebellar ataxia in paraneoplastic syn-
dromes [27]. While through these studies there is a strong
association of CA8 mutations with Purkinje cell death and
cerebellar ataxia, only little is known about CA8 function in
Purkinje cells. Our findings that CA8mRNA is approximately
2-fold increased and that its protein shows a 6-fold increase in
Purkinje cells of PKCγ-S361G transgenic mice suggest that it
may be involved in the signaling events downstream of PKC
activation. In view of the reported interaction between CA8
and ITPR1 [21], we have now shown that ITPR1 is strongly
induced in Purkinje cells from PKCγ-S361G transgenic mice.
Mutations in ITPR1 are causing spinocerebellar ataxia [28,
29], linking the final outcome of disturbances of PKCγ,
CA8, and ITPR1 and suggesting that these proteins may in-
teract functionally for the control of Purkinje cell synaptic
function and dendritic development.
PKCγ, CA8, and ITPR1 Do Not Co-immunoprecipitate
CA8 was previously identified as a protein binding to ITPR1
in a yeast two hybrid screen, and the interaction was con-
firmed with a GST pull-down assay [21]. In a recent report,
CA8 was shown to modulate pain sensation in sensory neu-
rons by inhibiting ITPR1-mediated signaling and calcium re-
lease [30]. Although the ITPR1 was not originally identified
as being upregulated in our gene chip screening (because the p
value was slightly above 0.05), we have confirmed that it is
also increased with an almost 5-fold-increased protein expres-
sion in Purkinje cells with activated PKC. In the classical
signaling pathway, both PKCγ and the ITPR1 are activated
in parallel via diacylglycerol (DAG) and IP3. It is an interest-
ing finding that a chronic activation of PKC induces a strong
induction of the protein expression of ITPR1 and the pre-
sumed interacting protein CA8. The activation of the PKC
pathway thus induces an induction of its parallel pathway
which is activated by IP3. This could mean that these path-
ways are not only linked by the common activation by DAG
and IP3 but that PKC activation by itself can recruit the par-
allel IP3 pathway. The exact mechanism of this interaction
still needs to be determined. It is well known that the IP3
receptor is a target of PKC phosphorylation and that phos-
phorylation changes the IP3-induced calcium release [31].
Our finding suggests that PKC-mediated phosphorylation of
the ITPR1 may eventually increase the protein expression of
this receptor.
Despite the parallel rise of protein expression of ITPR1 and
CA8 in Purkinje cells of PKCγ-S361G transgenic mice and the
finding that an interaction between these two proteins was iden-
tified in a yeast two hybrid screen and by a GST pull-down
assay [21], we could not show a co-immunoprecipitation of
CA8 and ITPR1 in Purkinje cells. Neither ITPR1 nor PKCγ
co-immunoprecipitated with CA8. Similarly, in the Duolink
proximity assay, no evidence for a close interaction was found
(data not shown). Of course we cannot exclude that this failure
to demonstrate a direct binding was due to technical limitations,
but both proteins are solidly expressed, and we have tried dif-
ferent immunoprecipitation protocols, none of which was
showing co-immunoprecipitation (data not shown). Therefore,
the exact nature of the interaction between PKCγ, CA8, and
ITPR1 in Purkinje cells still needs to be studied further.
CA8 and Purkinje Cell Dendritic Development
The strong upregulation of CA8 with activation of PKCγ
raises the possibility that CA8 is directly or indirectly involved
in the stunted growth of the Purkinje cell dendritic tree seen
with constitutive activation of PKCγ in PKCγ-S361G trans-
genic mice. We have addressed this issue by overexpressing
CA8 in dissociated Purkinje cell cultures. The dissociated cul-
ture system is of course less complex and more artificial com-
pared to organotypic slice cultures, but it allows to reliably
transfect Purkinje cells by electroporation and the use of an
L7-based Purkinje cell-specific expression vector [17].
Purkinje cells derived from PKCγ-S361G transgenic mice
show a much reduced dendritic development in such cultures,
and also, transfection of a PKCγ-S361G plasmid resulted in a
strong reduction of dendritic outgrowth (Fig. 6), indicating
that the dissociated culture does indeed reflect the changes
of dendritic outgrowth originally seen in organotypic slice
cultures. When Purkinje cells were transfected with a CA8
plasmid resulting in CA8 overexpression, a similar stunted
dendritic growth was observed as seen after overexpression
of PKCγ or of the mutated PKCγ-S361G (Fig. 6). This find-
ing shows that CA8 function does have an inhibitory effect on
Purkinje cell dendritic growth and that it is likely that PKCγ
and CA8 are both part of a common or related signaling path-
way eventually controlling dendritic outgrowth and retraction.
If CA8 was a downstream effector of PKC activation, a loss of
function of CA8 should reduce the effects of PKCγ on the
Purkinje cell dendrites. To this end, we have used transfection
of miRNA in order to suppress CA8 expression. After trans-
fection with miRNA, protein expression of CA8 was reduced
to a degree that cells were only weakly detected by immuno-
histochemistry (Fig. 7), confirming an efficient suppression of
CA8 protein expression by the miRNA. Despite this marked
reduction of CA8 expression, activation of PKC with PMA
still showed the typical stunted dendritic growth indicating
that CA8 is not required for this effect. There was also no
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rescue of the stunted dendritic tree by CA8 knockdown in
Purkinje cells derived from PKCγ-S361G transgenic mice.
While these findings leave open the possibility that the small
residual amount of CA8 protein present in Purkinje cells with
CA8 knockdown is sufficient for mediating the effects of
PKCγ activation, they make it very unlikely that CA8 is the
dominant mediator of PKCγ activation. They leave open the
possibility that CA8 may be more loosely associated with
PKCγ signaling or that its function might be redundant with
another yet to be identified mediator of PKCγ activation.
Conclusions
In this study we have identified CA8 and the ITPR1 as two
genes with strongly increased expression in Purkinje cells
with chronic activation of PKCγ. We could not find evidence
for a direct interaction of CA8 with the ITPR1 but show that
overexpression of CA8 in Purkinje cells results in a phenotype
with stunted dendritic growth similar to that seen after activa-
tion or overexpression of PKCγ. Although CA8 is probably
not a direct mediator of PKCγ for the effects on dendritic
growth, it is likely to be part of a larger signaling network
including PKCγ and the ITPR1 which controls synaptic func-
tion and dendritic growth of Purkinje cells.
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